Impact of chronic subthalamic high-frequency stimulation on metabolic basal ganglia activity: A 2-deoxyglucose uptake and cytochrome oxidase mRNA study in a macaque model of Parkinson's disease

European Journal of Neuroscience

Volumn 25, Issue 5, 2007, Pages 1492-1500

  Meissner, Wassilios ^a,b,c   Guigoni, Celine ^a   Cirilli, Laetitia ^a   Garret, Maurice ^a   Bioulac, Bernard H ^a   Gross, Christian E ^a   Bezard, Erwan ^a   Benazzouz, Abdelhamid ^a  

^a UMR 5287   (France)

^b HÔPITAL PELLEGRIN   (France)

^c CNRS   (France)

Author keywords

Basal ganglia; Deep brain stimulation; Globus pallidus internalis; Motor thalamus; STN; Subthalamic nucleus

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CYTOCHROME C OXIDASE; CYTOCHROME C OXIDASE SUBUNIT 1; DEOXYGLUCOSE; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASAL GANGLION; BRAIN DEPTH STIMULATION; BRAIN FUNCTION; BRAIN METABOLISM; BRAIN NERVE CELL; CONTROLLED STUDY; ENZYME SUBUNIT; EXPERIMENTAL MODEL; FEMALE; GENE EXPRESSION; GLOBUS PALLIDUS; GLUCOSE TRANSPORT; MACACA; NERVE CELL STIMULATION; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBTHALAMIC NUCLEUS; SYNAPTIC TRANSMISSION; THALAMUS VENTRAL NUCLEUS;

ANIMALS; BASAL GANGLIA; DEOXYGLUCOSE; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; ELECTRIC STIMULATION THERAPY; ELECTRON TRANSPORT COMPLEX IV; FEMALE; GENE EXPRESSION REGULATION; MACACA FASCICULARIS; PARKINSONIAN DISORDERS; RNA, MESSENGER; STATISTICS, NONPARAMETRIC; SUBTHALAMIC NUCLEUS;

EID: 34147108640     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2007.05406.x     Document Type: Article

References (80)

1. Alexander, G.E. & Crutcher, M.D. (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci., 13, 266-271.
2. Anderson, M.E., Postupna, N. & Ruffo, M. (2003) Effects of high-frequency stimulation in the internal globus pallidus on the activity of thalamic neurons in the awake monkey. J. Neurophysiol., 89, 1150-1160.
3. Asanuma, K., Tang, C., Ma, Y., Dhawan, V., Mattis, P., Edwards, C., Kaplitt, M.G., Feigin, A. & Eidelberg, D. (2006) Network modulation in the treatment of Parkinson's disease. Brain, 129, 2667-2678.
4. Aubert, I., Guigoni, C., Hakansson, K., Li, Q., Dovero, S., Barthe, N., Bioulac, B.H., Gross, C.E., Fisone, G., Bloch, B. & Bezard, E. (2005) Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia. Ann. Neurol., 57, 17-26.
5. Aziz, T.Z., Peggs, D., Agarwal, E., Sambrook, M.A. & Crossman, A.R. (1992) Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-exposed primate. Br. J. Neurosurg., 6, 575-582.
6. Bacci, J.J., El-Absi, H., Manrique, C., Baunez, C., Salin, P. & Kerkerian-Le Goff, L. (2004) Differential effects of prolonged high frequency stimulation and of excitotoxic lesion of the subthalamic nucleus on dopamine denervation-induced cellular defects in the rat striatum and globus pallidus. Eur. J. Neurosci., 20, 3331-3341.
7. Benabid, A.L., Wallace, B., Mitrofanis, J., Xia, R., Piallat, B., Chabardes, S. & Berger, F. (2005) A putative generalized model of the effects and mechanism of action of high frequency electrical stimulation of the central nervous system. Acta Neurol. Belg., 105, 149-157.
8. Benazzouz, A., Boraud, T., Dubedat, P., Boireau, A., Stutzmann, J.M. & Gross, C. (1995) Riluzole prevents MPTP-induced parkinsonism in the rhesus monkey: a pilot study. Eur. J. Pharmacol., 284, 299-307.
9. Benazzouz, A., Breit, S., Koudsie, A., Pollak, P., Krack, P. & Benabid, A.L. (2002) Intraoperative microrecordings of the subthalamic nucleus in Parkinson's disease. Mov Disord., 17 (Suppl. 3), S145-S149.
10. Benazzouz, A., Gross, C., Feger, J., Boraud, T. & Bioulac, B. (1993) Reversal of rigidity and improvement in motor performance by subthalamic high-frequency stimulation in MPTP-treated monkeys. Eur. J. Neurosci., 5, 382-389.
11. Benazzouz, A., Tai, C.H., Meissner, W., Bioulac, B., Bezard, E. & Gross, C. (2004) High-frequency stimulation of both zona incerta and subthalamic nucleus induces a normalization of basal ganglia metabolic activity in experimental parkinsonism. FASEB J., 18, 528-530.
12. Bergman, H., Wichmann, T. & DeLong, M.R. (1990) Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science, 249, 1436-1438.
13. Bezard, E., Crossman, A.R., Gross, C.E. & Brotchie, J.M. (2001a) Structures outside the basal ganglia may compensate for dopamine loss in the presymptomatic stages of Parkinson's disease. FASEB J., 15, 1092-1094.
14. Bezard, E., Dovero, S., Prunier, C., Ravenscroft, P., Chalon, S., Guilloteau, D., Crossman, A.R., Bioulac, B., Brotchie, J.M. & Gross, C.E. (2001b) Relationship between the appearance of symptoms and the level of nigrostriatal degeneration in a progressive 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-lesioned macaque model of Parkinson's disease. J. Neurosci., 21, 6853-6861.
15. Bezard, E., Ferry, S., Mach, U.H.S., Leriche, L., Boraud, T., Gross, C.E. & Sokoloff, P. (2003) Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function. Nat. Med., 9, 762-767.
16. Boraud, T., Bezard, E., Bioulac, B. & Gross, C.E. (2001) Dopamine agonist-induced dyskinesias are correlated to both firing pattern and frequency alterations of pallidal neurones in the MPTP-treated monkey. Brain, 124, 546-557.
17. Boraud, T., Bezard, E., Bioulac, B. & Gross, C.E. (2002) From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control. Prog. Neurobiol., 66, 265-283.
18. Braak, H., Rub, U., Sandmann-Keil, D., Gai, W.P., de Vos, R.A.I., Steur, E., Arai, K. & Braak, E. (2000) Parkinson's disease: affection of brain stem nuclei controlling premotor and motor neurons of the somatomotor system. Acta Neuropathol., 99, 489-495.
19. Brown, P., Mazzone, P., Oliviero, A., Altibrandi, M.G., Pilato, F. & Di Tonali, P.A. &.,.V. (2004) Effects of stimulation of the subthalamic area on oscillatory pallidal activity in Parkinson's disease. Exp. Neurol., 188, 480-490.
20. Bruet, N., Windels, F., Bertrand, A., Feuerstein, C., Poupard, A. & Savasta, M. (2001) High frequency stimulation of the subthalamic nucleus increases the extracellular contents of striatal dopamine in normal and partially dopaminergic denervated rats. J. Neuropathol. Exp. Neurol., 60, 15-24.
21. Ceballos-Baumann, A.O., Boecker, H., von Bartenstein, P.F.I., Riescher, H., Conrad, B., Moringlane, J.R. & Alesch, F. (1999) A positron emission tomographic study of subthalamic nucleus stimulation in Parkinson disease: enhanced movement-related activity of motor association cortex and decreased motor cortex resting activity. Arch. Neurol., 56, 997-1003.
22. Darbaky, Y., Forni, C., Amalric, M. & Baunez, C. (2003) High frequency stimulation of the subthalamic nucleus has beneficial antiparkinsonian effects on motor functions in rats, but less efficiency in a choice reaction time task. Eur. J. Neurosci., 18, 951-956.
23. Féger, J. & Robledo, P. (1991) The Effects of Activation or Inhibition of the Subthalamic Nucleus on the Metabolic and Electrophysiological Activities Within the Pallidal Complex and Substantia Nigra in the Rat. Eur. J. Neurosci., 3, 947-952.
24. Filali, M., Hutchison, W.D., Palter, V.N., Lozano, A.M. & Dostrovsky, J.O. (2004) Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus. Exp. Brain Res., 156, 274-281.
25. Francois, C., Tande, D., Yelnik, J. & Hirsch, E.C. (2002) Distribution and morphology of nigral axons projecting to the thalamus in primates. J. Comp. Neurol., 447, 249-260.
26. Garcia, L., Audin, J., D'Alessandro, G., Bioulac, B. & Hammond, C. (2003) Dual effect of high-frequency stimulation on subthalamic neuron activity. J. Neurosci., 23, 8743-8751.
27. Gill, S.S. & Heywood, P. (1997) Bilateral dorsolateral subthalamotomy for advanced Parkinson's disease. Lancet, 350, 1224.
28. Goldberg, J.A., Boraud, T., Maraton, S., Haber, S.N., Vaadia, E. & Bergman, H. (2002) Enhanced synchrony among primary motor cortex neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine primate model of Parkinson's disease. J. Neurosci., 22, 4639-4653.
29. Guigoni, C., Li, Q., Aubert, I., Dovero, S., Bioulac, B.H., Bloch, B., Crossman, A.R., Gross, C.E. & Bezard, E. (2005) Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine- induced dyskinesia. J. Neurosci., 25, 2102-2107.
30. Hashimoto, T., Elder, C.M., Okun, M.S., Patrick, S.K. & Vitek, J.L. (2003) Stimulation of the subthalamic nucleus changes the firing pattern of pallidal neurons. J. Neurosci., 23, 1916-1923.
31. Haslinger, B., Kalteis, K., Boecker, H., Alesch, F. & Ceballos-Baumann, A.O. (2005) Frequency-correlated decreases of motor cortex activity associated with subthalamic nucleus stimulation in Parkinson's disease. Neuroimage, 28, 598-606.
32. Hershey, T., Revilla, F.J., Wernle, A.R., McGee-Minnich, L., Antenor, J.V., Videen, T.O., Dowling, J.L., Mink, J.W. & Perlmutter, J.S. (2003) Cortical and subcortical blood flow effects of subthalamic nucleus stimulation in PD. Neurology, 61, 816-821.
33. Hevner, R.F., Liu, S. & Wong-Riley, M.T. (1995) A metabolic map of cytochrome oxidase in the rat brain: histochemical, densitomeric and biochemical analysis. Neuroscience, 65, 313-342.
34. Hilker, R., Voges, J., Weisenbach, S., Kalbe, E., Burghaus, L., Ghaemi, M., Lehrke, R., Koulousakis, A., Herholz, K., Sturm, V. & Heiss, W.D. (2004) Subthalamic nucleus stimulation restores glucose metabolism in associative and limbic cortices and in cerebellum: evidence from a FDG-PET study in advanced Parkinson's disease. J. Cereb. Blood Flow Metab., 24, 7-16.
35. Holsheimer, J., Demeulemeester, H., Nuttin, B. & de Sutter, P. (2000) Identification of the target neuronal elements in electrical deep brain stimulation. Eur. J. Neurosci., 12, 4573-4577.
36. Hutchison, W.D., Dostrovsky, J.O., Walters, J.R., Courtemanche, R., Boraud, T., Goldberg, J. & Brown, P. (2004) Neuronal oscillations in the basal ganglia and movement disorders: evidence from whole animal and human recordings. J. Neurosci., 24, 9240-9243.
37. Ilinsky, I.A., Tourtellotte, W.G. & Kultas-Ilinsky, K. (1993) Anatomical distinctions between the two basal ganglia afferent territories in the primate motor thalamus. Stereotact. Funct. Neurosurg., 60, 62-69.
38. Imbert, C., Bezard, E., Guitraud, S., Boraud, T. & Gross, C.E. (2000) Comparison between eight clinical rating scales used for the assessment of MPTP-induced parkinsonism in the macaque monkey. J. Neurosci. Meth., 96, 71-76.
39. Kumar, R., Lozano, A.M., Kim, Y.J., Hutchison, W.D., Sime, E., Halket, E. & Lang, A.E. (1998) Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology, 51, 850-855.
40. Limousin, P., Greene, J., Pollak, P., Rothwell, J., Benabid, A.L. & Frackowiak, R. (1997) Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann. Neurol., 42, 283-291.
41. Limousin, P., Krack, P., Pollak, P., Benazzouz, A., Ardouin, C., Hoffmann, D. & Benabid, A.L. (1998) Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med., 339, 1105-1111.
42. Limousin, P., Pollak, P., Benazzouz, A., Hoffmann, D., Le Bas, J.F., Broussolle, E., Perret, J.E. & Benabid, A.L. (1995) Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet, 345, 91-95.
43. Lozano, A.M., Dostrovsky, J., Chen, R. & Ashby, P. (2002) Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol., 1, 225-231.
44. Magarinos-Ascone, C., Pazo, J.H., Macadar, O. & Buno, W. (2002) High-frequency stimulation of the subthalamic nucleus silences subthalamic neurons: a possible cellular mechanism in Parkinson's disease. Neuroscience, 115, 1109-1117.
45. Maurice, N., Thierry, A.M., Glowinski, J. & Deniau, J.M. (2003) Spontaneous and evoked activity of substantia nigra pars reticulata neurons during high-frequency stimulation of the subthalamic nucleus. J. Neurosci., 23, 9929-9936.
46. McIntyre, C.C., Grill, W.M., Sherman, D.L. & Thakor, N.V. (2004) Cellular effects of deep brain stimulation: model-based analysis of activation and inhibition. J. Neurophysiol., 91, 1457-1469.
47. Meissner, W., Dovero, S., Bioulac, B., Gross, C.E. & Bezard, E. (2003a) Compensatory regulation of striatal neuropeptide gene expression occurs before changes in metabolic activity of basal ganglia nuclei. Neurobiol. Dis., 13, 46-54.
48. Meissner, W., Gross, C.E., Harnack, D., Bioulac, B. & Benazzouz, A. (2004) Deep brain stimulation for Parkinson's disease: potential risk of tissue damage associated with external stimulation. Ann. Neurol., 55, 449-450.
49. Meissner, W., Harnack, D., Reese, R., Paul, G., Reum, T., Ansorge, M., Kusserow, H., Winter, C., Morgenstern, R. & Kupsch, A. (2003b) High-frequency stimulation of the subthalamic nucleus enhances striatal dopamine release and metabolism in rats. J. Neurochem., 85, 601-609.
50. Meissner, W., Leblois, A., Hansel, D., Bioulac, B., Gross, C.E., Benazzouz, A. & Boraud, T. (2005) Subthalamic high frequency stimulation resets subthalamic firing and reduces abnormal oscillations. Brain, 128, 2372-2382.
51. Mitchell, I.J., Clarke, C.E., Boyce, S., Robertson, R.G., Peggs, D., Sambrook, M.A. & Crossman, A.R. (1989) Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neuroscience, 32, 213-226.
52. Nowak, L.G. & Bullier, J. (1998a) Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. I. Evidence from chronaxie measurements. Exp. Brain Res., 118, 477-488.
53. Nowak, L.G. & Bullier, J. (1998b) Axons, but not cell bodies, are activated by electrical stimulation in cortical gray matter. II. Evidence from selective inactivation of cell bodies and axon initial segments. Exp. Brain Res., 118, 489-500.
54. Nutt, J.G., Rufener, S.L., Carter, J.H., Anderson, V.C., Pahwa, R., Hammerstad, J.P. & Burchiel, K.J. (2001) Interactions between deep brain stimulation and levodopa in Parkinson's disease. Neurology, 57, 1835-1842.
55. Obeso, J.A., Alvarez, L.M., Macias, R.J., Guridi, J., Teijeiro, J., Juncos, J.L., Rodriguez, M.C., Ramos, E., Linazasoro, G.J., Gorospe, A. & DeLong, M.R. (1997) Lesion of the subthalamic nucleus in Parkinson's disease. Neurology, 48 (Suppl. 2), A138.
56. Pahapill, P.A. & Lozano, A.M. (2000) The pedunculopontine nucleus and Parkinson's disease. Brain, 123, 1767-1783.
57. Parent, A. & Hazrati, L.-N. (1995) Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res. Rev., 20, 91-127.
58. Payoux, P., Remy, P., Damier, P., Miloudi, M., Loubinoux, I., Pidoux, B., Gaura, V., Rascol, O., Samson, Y. & Agid, Y. (2004) Subthalamic nucleus stimulation reduces abnormal motor cortical overactivity in Parkinson disease. Arch. Neurol., 61, 1307-1313.
59. Percheron, G., François, C., Talbi, B., Yelnik, J. & Fenelon, G. (1996) The primate motor thalamus. Brain Res. Rev., 22, 93-181.
60. Pessiglione, M., Guehl, D., Rolland, A.S., Francois, C., Hirsch, E.C., Feger, J. & Tremblay, L. (2005) Thalamic neuronal activity in dopamine-depleted primates: evidence for a loss of functional segregation within basal ganglia circuits. J. Neurosci., 25, 1523-1531.
61. Pollak, P., Krack, P., Fraix, V., Mendes, A., Moro, E., Chabardes, S. & Benabid, A.L. (2002) Intraoperative micro- and macrostimulation of the subthalamic nucleus in Parkinson's disease. Mov Disord., 17 (Suppl. 3), S155-S161.
62. Porrino, L.J., Burns, R.S., Crane, A.M., Palombo, E., Kopin, I.J. & Sokoloff, L. (1987) Changes in local cerebral glucose utilization associated with Parkinson's disease syndrome induced by 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP) in the primate. Life Sci., 40, 1657-1664.
63. Raz, A., Vaadia, E. & Bergman, H. (2000) Firing patterns and correlations of spontaneous discharge of pallidal neurons in the normal and the tremulous 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine vervet model of parkinsonism. J. Neurosci., 20, 8559-8571.
64. Salin, P., Manrique, C., Forni, C. & Goff, L.K. (2002) High-frequency stimulation of the subthalamic nucleus selectively reverses dopamine denervation-induced cellular defects in the output structures of the Basal Ganglia in the rat. J. Neurosci., 22, 5137-5148.
65. Sestini, S., Ramat, S., Formiconi, A.R., Ammannati, F., Sorbi, S. & Pupi, A. (2005) Brain networks underlying the clinical effects of long-term subthalamic stimulation for Parkinson's disease: a 4-year follow-up study with rCBF SPECT. J. Nucl. Med., 46, 1444-1454.
66. 14C]-deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem., 28, 897-916.
67. Stefani, A., Fedele, E., Galati, S., Pepicelli, O., Frasca, S., Pierantozzi, M., Peppe, A., Brusa, L., Orlacchio, A., Hainsworth, A.H., Gattoni, G., Stanzione, P., Bernardi, G., Raiteri, M. & Mazzone, P. (2005) Subthalamic stimulation activates internal pallidus: evidence from cGMP microdialysis in PD patients. Ann. Neurol., 57, 448-452.
68. Szabo, J. & Cowan, W.M. (1984) A stereotaxic atlas of the brain of the cynomolgus monkey (macaca fascicularis). J. Comp. Neurol., 222, 265-300.
69. Tai, C.H., Boraud, T., Bezard, E., Bioulac, B., Gross, C. & Benazzouz, A. (2003) Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. FASEB J., 17, 1820-1830.
70. Temperli, P., Ghika, J., Villemure, J.G., Burkhard, P.R., Bogousslavsky, J. & Vingerhoets, F.J. (2003) How do parkinsonian signs return after discontinuation of subthalamic DBS? Neurology, 60, 78-81.
71. Trost, M., Su, S., Su, P., Yen, R.F., Tseng, H.M., Barnes, A., Ma, Y. & Eidelberg, D. (2006) Network modulation by the subthalamic nucleus in the treatment of Parkinson's disease. Neuroimage, 31, 301-307.
72. Vafaee, M.S. & Gjedde, A. (2004) Spatially dissociated flow-metabolism coupling in brain activation. Neuroimage, 21, 507-515.
73. Vafaee, M.S., Ostergaard, K., Sunde, N., Gjedde, A., Dupont, E. & Cumming, P. (2004) Focal changes of oxygen consumption in cerebral cortex of patients with Parkinson's disease during subthalamic stimulation. Neuroimage, 22, 966-974.
74. Vila, M., Levy, R., Herrero, M.T., Faucheux, B., Obeso, J.A., Agid, Y. & Hirsch, E.C. (1996) Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study. Neuroscience, 71, 903-912.
75. Vila, M., Perier, C., Feger, J., Yelnik, J., Faucheux, B., Ruberg, M., Raisman-Vozari, R., Agid, Y. & Hirsch, E.C. (2000) Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed by metabolic and electrophysiological measurements. Eur. J. Neurosci., 12, 337-344.
76. Welter, M.L., Houeto, J.L., Bonnet, A.M., Bejjani, P.B., Mesnage, V., Dormont, D., Navarro, S., Cornu, P., Agid, Y. & Pidoux, B. (2004) Effects of high-frequency stimulation on subthalamic neuronal activity in parkinsonian patients. Arch. Neurol., 61, 89-96.
77. Wichmann, T., Bergman, H., Starr, P.A., Subramanian, T., Watts, R.L. & DeLong, M.R. (1999) Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp. Brain Res., 125, 397-409.
78. Windels, F., Bruet, N., Poupard, A., Urbain, N., Chouvet, G., Feuerstein, C. & Savasta, M. (2000) Effects of high frequency stimulation of subthalamic nucleus on extracellular glutamate and GABA in substantia nigra and globus pallidus in the normal rat. Eur. J. Neurosci., 12, 4141-4146.
79. Windels, F., Carcenac, C., Poupard, A. & Savasta, M. (2005) Pallidal origin of GABA release within the substantia nigra pars reticulata during high-frequency stimulation of the subthalamic nucleus. J. Neurosci., 25, 5079-5086.
80. Wong-Riley, M. (1979) Changes in the visual system of monocularly stutured or enucleated cats demonstrable with cytochrome oxidase histochemistry. Brain Res., 171, 11-28.